EP3215132
AMANTADINE FOR IMPROVING GAIT IN MULTIPLE SCLEROSIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.11.2015EP published:
27.1.2021EP application number:
15857591.0
EPO information:
European Patent Register
Max expiry date:
2.11.2035
Title:
AMANTADINE FOR IMPROVING GAIT IN MULTIPLE SCLEROSIS
Timeline
Today
3.11.2015EP application
27.1.2021EP Publication
Owner
Name:
Adamas Pharmaceuticals, Inc.Address:
1900 Powell Street, Suite 750, Emeryville, CA 94608, US
Inventor
Name:
WENT, Gregory T.Address:
Mill Valley, California 94941, US
Name:
FULTZ, Timothy J.Address:
Jasper, Georgia 30143, US
Name:
NGUYEN, JackAddress:
Berkeley, California 94705, US
Name:
CHERNOFF, DavidAddress:
Sausalito, California 94965, US
Priority
Number:
201462075137 PDate:
4.11.2014Country:
US
Classification
Categories:
A61K 31/13, A61K 9/48, A61K 9/50, A61P 21/00